RBOT Community Narratives

AnalystConsensusTarget's

Fair Value

Fair Value US$5 80.1% undervalued

Long-Term Robotic Surgery Adoption And Design Freeze Milestones Will Support A Bullish Thesis

About RBOT

Founded: 2014
Employees: 26
CEO: Stephen From
WebsiteView website: www.vicarioussurgical.com

Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts.

Recent RBOT News & Updates

Announcement • Apr 01

Vicarious Surgical Inc. Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Inc. announced the successful completion of initial integrated benchtop testing for its full suite of surgical instruments, required for its anticipated first clinical indication of ventral hernia repair, marking an important step toward design validation, clinical readiness, and the Company’s targeted design freeze milestone. This milestone represents the first system-level performance evaluation of the Company's three core instruments: needle drivers, fenestrated graspers, and monopolar scissors, each of which is designed for use with the Vicarious Surgical System. The successful testing of all three instruments in a unified evaluation serves as a critical step in systematically de-risking the Company's path toward first-in-human use. Notably, the monopolar scissors, which previously demonstrated successful electrical performance in a December porcine lab study, exhibited strong motion and mechanical cutting capabilities following the Company's standard automated calibration and bring-up process. Importantly, instrument and camera sensors remained stable, with no degradation in video or motion quality in the presence of monopolar electrosurgical energy, confirming robust system performance under clinically relevant operating conditions. The successful completion of this benchtop testing positions the Company to advance to the next phase of preclinical validation, including planned cadaveric and porcine studies, as it continues to prepare for first clinical use of the Vicarious Surgical System and execute against a defined series of development milestones leading to design freeze.

Recent updates

No updates

Vicarious Surgical Inc. Stock Price

RBOT Share Price Performance

RBOT Community Narratives

Long-Term Robotic Surgery Adoption And Design Freeze Milestones Will Support A Bullish Thesis

Long-Term Robotic Surgery Adoption And Design Freeze Milestones Will Support A Bullish Thesis

Trending Discussion

Recently Updated Narratives

Long-Term Robotic Surgery Adoption And Design Freeze Milestones Will Support A Bullish Thesis

Snowflake Analysis

Vicarious Surgical Inc. Key Details

About RBOT

Recent RBOT News & Updates

Vicarious Surgical Inc Demonstrates Sustained System Performance And Complex Hernia Procedure Workflows In Pre-Clinical Setting

Vicarious Surgical Inc. Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Long-Term Robotic Surgery Adoption And Design Freeze Milestones Will Support A Bullish Thesis

Recent updates

Vicarious Surgical Inc. Competitors

Wellgistics Health

Co-Diagnostics

Cosmos Health

Trinity Biotech